Cargando…
The use of stem cells in ischemic heart disease treatment
Ischemic heart disease is a major cause of death and disabilities worldwide. Unfortunately, not all patients are suitable for direct revascularization. Cell-based therapies may be alternative options because of their potential to promote neovascularisation and endothelial repair, improving myocardia...
Autores principales: | Litwinowicz, Radoslaw, Kapelak, Bogusław, Sadowski, Jerzy, Kędziora, Anna, Bartus, Krzysztof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180025/ https://www.ncbi.nlm.nih.gov/pubmed/30310400 http://dx.doi.org/10.5114/kitp.2018.78446 |
Ejemplares similares
-
Clinical factors predicting blood pressure reduction after catheter-based renal denervation
por: Bartus, Krzysztof, et al.
Publicado: (2018) -
Ischemic stroke after left atrial appendage occlusion with LARIAT in a patient with a coagulation disorder and unrecognized carotid artery stenosis
por: Bartus, Krzysztof, et al.
Publicado: (2020) -
Response to Letter to the Editor “Adverse outcomes in anticoagulated patients undergoing percutaneous left atrial appendage ligation” by Anetta Undas
por: Litwinowicz, Radoslaw, et al.
Publicado: (2020) -
Decrease of surgical heart disease treatment during the COVID-19 pandemic (Cardiac Surgery COVID-19 Study – CSC 19 Study)
por: Litwinowicz, Radoslaw, et al.
Publicado: (2022) -
Coronary artery bypass grafting after left atrial appendage ligation – is anti-inflammatory treatment after LARIAT effective?
por: Bartuś, Krzysztof, et al.
Publicado: (2018)